New York Magazine: Does eating chocolate actually trigger migraines?
Migraine sufferers can find dozens of articles online claiming that chocolate can trigger migraines, but there is little solid scientific evidence that this is true.
That's what the University of Cincinnati's Vincent Martin, MD, told a reporter for New York Magazine's The Cut.
Martin, professor in the Department of Internal Medicine in UC's College of Medicine, said there haven't been many experimental studies designed to test which foods trigger migraines because "they're expensive to do." He added that funding for migraine research is "abysmal" because it is not a fatal condition, but migraines are the second leading cause of time lost to disability worldwide.
The research we do have suggests "no foods have great evidence" as migraine triggers, and if chocolate does trigger migraines, "it's probably a rather rare event," Martin said.
Read the New York Magazine/The Cut article.
Featured photo at top of assorted chocolates. Photo/Jessica Loaiza/Unsplash.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.